- Home
- ALDX vs PDEX Comparison
ALDX vs PDEX Comparison
Compare ALDX & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- PDEX
- Stock Information
- Founded
- ALDX 2004
- PDEX 1978
- Country
- ALDX United States
- PDEX United States
- Employees
- ALDX N/A
- PDEX N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- PDEX Medical/Dental Instruments
- Sector
- ALDX Health Care
- PDEX Health Care
- Exchange
- ALDX Nasdaq
- PDEX Nasdaq
- Market Cap
- ALDX 160.8M
- PDEX 167.6M
- IPO Year
- ALDX 2014
- PDEX N/A
- Fundamental
- Price
- ALDX $4.76
- PDEX $45.03
- Analyst Decision
- ALDX Strong Buy
- PDEX Strong Buy
- Analyst Count
- ALDX 2
- PDEX 1
- Target Price
- ALDX $9.50
- PDEX $56.00
- AVG Volume (30 Days)
- ALDX 1.2M
- PDEX 70.4K
- Earning Date
- ALDX 07-31-2025
- PDEX 09-04-2025
- Dividend Yield
- ALDX N/A
- PDEX N/A
- EPS Growth
- ALDX N/A
- PDEX 379.10
- EPS
- ALDX N/A
- PDEX 2.76
- Revenue
- ALDX N/A
- PDEX $64,123,999.00
- Revenue This Year
- ALDX N/A
- PDEX $26.92
- Revenue Next Year
- ALDX N/A
- PDEX $4.48
- P/E Ratio
- ALDX N/A
- PDEX $17.28
- Revenue Growth
- ALDX N/A
- PDEX 29.65
- 52 Week Low
- ALDX $1.14
- PDEX $17.34
- 52 Week High
- ALDX $7.20
- PDEX $70.26
- Technical
- Relative Strength Index (RSI)
- ALDX 78.74
- PDEX 50.41
- Support Level
- ALDX $4.12
- PDEX $46.38
- Resistance Level
- ALDX $4.60
- PDEX $49.09
- Average True Range (ATR)
- ALDX 0.29
- PDEX 2.28
- MACD
- ALDX 0.08
- PDEX 0.56
- Stochastic Oscillator
- ALDX 90.91
- PDEX 50.82
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About PDEX Pro-Dex Inc.
Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.